DSM Submits “Final” GMP Report To FDA; New Quality Systems In Place
Executive Summary
DSM Pharmaceuticals is highlighting new environmental monitoring systems in its response to FDA about recent good manufacturing practices inspections
You may also be interested in...
From DSM to ICN
Former DSM Pharmaceuticals CEO Wesley Wheeler is named North American president of ICN Pharmaceuticals. Company notes that Wheeler has experience with "business turnarounds," cites his tenure at DSM. Wheeler joined the contract manufacturing firm as part of a management overhaul following several problematic FDA inspections. Prior to joining DSM, Wheeler was senior VP-logistics & strategy for GlaxoSmithKline (1"The Pink Sheet" Sept. 30, 2002, p. 30)...
From DSM to ICN
Former DSM Pharmaceuticals CEO Wesley Wheeler is named North American president of ICN Pharmaceuticals. Company notes that Wheeler has experience with "business turnarounds," cites his tenure at DSM. Wheeler joined the contract manufacturing firm as part of a management overhaul following several problematic FDA inspections. Prior to joining DSM, Wheeler was senior VP-logistics & strategy for GlaxoSmithKline (1"The Pink Sheet" Sept. 30, 2002, p. 30)...
Catalytica Expects GMP Problems To Be Resolved During Latter Half Of 2002
DSM Catalytica expects to resolve all GMP problems at its Greenville, N.C. facility in the second half of 2002